Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
This is a 45.5% decrease from the number of companies inspected in the previous year, when 11 companies were inspected through 12 inspections.
Most of the companies inspected were involved in the Food/Cosmetics and Biologics sectors. The second most common type of company inspected in the time period worked in the Drugs and Devices sectors.
There were three companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. Three should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Boyajian, Inc. | Food/Cosmetics | 07/07/2023 | No Action Indicated (NAI) |
Emergent Biosolutions, LLC | Biologics | 08/16/2023 | Voluntary Action Indicated (VAI) |
Fresenius Kabi Compounding, LLC | Drugs | 03/06/2023 | Voluntary Action Indicated (VAI) |
Intera Oncology, Inc. | Devices | 04/05/2023 | No Action Indicated (NAI) |
ModernaTX, Inc. | Biologics | 09/21/2023 | Voluntary Action Indicated (VAI) |
Multiflow Industries, LLC | Food/Cosmetics | 05/31/2023 | No Action Indicated (NAI) |